![]() |
|||
|
|||
Drug-eluting stent implantation for radial artery
graft aorta-ostial stenosis
Ewan McKay, Kathryn A Ramsdale, David R Ramsdale
The use of the free radial artery (RA) graft in coronary
artery bypass surgery (CABG) was revived by Acar et al in 1992 with reports of
excellent early patency rates following improved harvesting
techniques.1 However, stenoses do occur within
RA grafts and severe intimal hyperplasia may result in occlusion unless early
angiography is performed in patients who develop recurrent angina soon after
undergoing CABG surgery.2–5
Percutaneous coronary intervention (PCI) is probably the
treatment of choice, but few cases have been reported in the
literature.6–9 We believe this is the
first case report of drug-eluting stent (DES) implantation to an aorta-ostial RA
stenosis, chosen to optimise both the early and the long-term outcome and avoid
the difficult-to-treat in-stent restenosis.
Case reportA 54-year-old man presented with recurrent angina 5 years
after CABG surgery, including left internal mammary artery to left anterior
descending coronary artery, free right internal mammary artery (RIMA) to the
occluded right coronary artery (RCA) and radial artery (RA) graft to the obtuse
marginal branch of the circumflex coronary artery (OMCX). Coronary arteriography
showed patent LIMA and RIMA but a severe aorta-ostial stenosis of the radial
artery graft (Figure 1a).
Figure 1. (a) Severe discrete aorta-ostial
stenosis (arrow) in a radial artery graft to the OMCX; (b) 2.75mm×20mm
Taxus™ stent positioned to cover the aorta-ostial lesion; (c) final result
after flaring the ostium of the stent.
![]() The lesion was crossed with a 0.014 inch floppy guidewire,
pre-dilated with a 2.5mm×10mm long Aqua™ balloon catheter—with
improvement, and stented with a 2.75mm×20mm long Taxus™ stent (Figure
1b) with an excellent angiographic result (Figure 1c). He immediately became
symptom-free and remains so after 4 years.
DiscussionThe use of the free RA in CABG surgery has only become
popular again in the last 15
years.1 A significant
attraction has been the possibility of better long-term patency compared to
saphenous vein grafts. Although some studies have reported 5-year patency rates
between 83% and 87% in asymptomatic
cases,2–4 in symptomatic patients they
may be as low as 51.2%.5
The incidence of severe stenoses in RA grafts and their
distribution along the length of the graft remain unclear, although Khot et al
reported 15.1% with severe stenoses (>70% or string sign) in their study of
symptomatic patients in addition to the 33.7% with
occlusions.5
When faced with recurrent angina and stenosed or occluded RA
grafts, repeat surgery is rarely considered, especially if the other conduits
are patent and disease-free. For severely stenosed RA grafts, PCI should be
preferable to additional medical treatment, although totally occluded RAs would
probably not be amenable to this. Surprisingly, however, PCI to RA stenoses have
rarely been reported.6–9
Aorta-ostial lesions are almost certainly due to
fibrointimal hyperplasia and like ostial lesions in saphenous vein grafts are
likely to be tough, resistant, and prone to recoil after balloon dilatation.
Stenting should attain the best acute result, reduce the incidence of
restenosis, and improve the long-term outcome. DES implantation should further
diminish the chance of in-stent restenosis—a particularly difficult
problem to deal with.
Although, late/very late thrombosis in drug-eluting stents
has been recognised as a serious problem (occurring in approximately 0.5% of
patients), the advantages of DES in this case outweigh the disadvantages.
Continuing aspirin and clopidogrel is also likely to reduce the incidence of
this phenomenon.
This case illustrates the first report of a
Paclitaxel-eluting stent implantation to an aorta-ostial radial artery graft
stenosis, demonstrating both an excellent acute angiographic and longer-term
clinical result. Further reports are required on the role of PCI and
drug-eluting stents in patients with RA graft lesions.
Author information: Ewan McKay, House
Physician; Kathryn A Ramsdale, House Physician; David R Ramsdale, Consultant
Cardiologist; The Cardiothoracic Centre, Liverpool, UK
Correspondence: Dr David R Ramsdale, The
Cardiothoracic Centre, Thomas Drive, Liverpool, L14 3PE, UK. Fax: +44 (0)151
2208573; email: David.Ramsdale@ctc.nhs.uk
References:
|
|||
| Current
issue | Search journal |
Archived issues | Classifieds
| Hotline (free ads) Subscribe | Contribute | Advertise | Contact Us | Copyright | Other Journals |